NASDAQ$CABA

Cabaletta Bio Inc · Q4 2018 earnings

Q4 2018 earnings · · Investor relations

Headline financials

EPS (adj)

-$0.52

No prior period
Net Income

-$1.91M

No prior period
Operating Income

-$2.07M

No prior period
Gross Profit

$0.00

No prior period
R&D Expense

$1.24M

No prior period

Revenue & EPS history

Cabaletta Bio · Revenue · Quarterly

$0

Q3 2025
Beat estimate in 0 of 1 quarters(0%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

+2.7%

Avg return

Earnings day

+3.2%

Avg return

5 days after

+5.3%

Avg return

30 days after

67%

16 / 24 earnings

Positive

+22.7%

Q3 2022

Best reaction

-24.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-7.8%-9.0%-16.2%
Q3 2025-5.0%-9.4%-5.1%
Q1 2025-0.6%+6.9%-2.9%
Q4 2024+12.8%-28.4%-14.8%
Q3 2024-24.4%-36.7%-29.7%
Q1 2024+12.4%+14.7%-5.1%
Q4 2023-4.2%-6.4%-26.4%
Q3 2023+4.0%+1.6%-5.6%
Q2 2023+10.0%+10.4%+12.0%
Q1 2023+1.6%+7.0%-1.2%
Q4 2022+9.3%+4.3%+5.4%
Q3 2022+22.7%+84.0%+207.2%
Q2 2022+19.5%+17.2%-26.3%
Q1 2022+21.1%+52.8%-3.3%
Q4 2021+14.6%+32.7%+6.4%
Q3 2021+2.4%-5.3%-19.1%
Q2 2021+2.0%+1.9%+58.0%
Q1 2021-6.6%-14.0%-7.2%
Q4 2020+1.7%-4.0%-8.7%
Q3 2020+6.7%+7.1%+19.3%
Q2 2020+6.4%+4.6%-15.8%
Q1 2020-9.3%-8.0%-8.0%
Q4 2019+0.3%-7.6%+10.7%
Q3 2019-23.7%-38.7%+3.7%
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro